Featured Research
- Mithoefer M, Grob C, Brewerton T (2016): Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3 (5): 481–488
- Heifets B, Malenk R (2016): MDMA as a Probe and Treatment for Social Behaviors. Cell 166: 269-272
- Brown, Alper (2017): Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes. The American Journal of Drug and Alcohol Abuse
- Noller, Frampton, Yazar-Klosinski (2017): Ibogaine treatment outcomes for opiod dependence from a twelve-month follow-up observational study. The American Journal of Drug and Alcohol Abuse
- Yazar-Klosinski, Mithoefer (2017): Potential Psychiatric Uses for MDMA. Clinical Pharmacology and Therapeutics., 101: 194–196. doi:10.1002/cpt.565